Worldwide Clinical Trials Polandsp. z o.o.
Other professional, scientific and technical activities not elsewhere classified
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2010-06-18
Share capital
330 000,00 PLN
Registered address
Rondo Ignacego Daszyńskiego 2B, 00-843 Warszawa, Poland
Financials
Revenue history (in m)
Filing timeliness
6 of 6 financial statements were filed late (the longest delay 383 days for 2020). 3 of 6 audited by a statutory auditor.
- 202505/10/2026
- 202416/07/2025
- 202313/09/2024
- 202228/07/2023
- 202102/11/2022
- 202002/11/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 10.72mMedianUSD 70.87kAverageUSD 519.44k
Net profit
This companyUSD 650.93kMedianUSD 2.54kAverageUSD 5.52k
Operating costs
This companyUSD 9.83mMedianUSD 57.18kAverageUSD 449.76k
Assets
This companyUSD 4.15mMedianUSD 61.02kAverageUSD 1.39m
Industry
Authorized Representatives
Andre Ganem – Management Board Member
Anthony Jason Merriman – Management Board Member
Manner of representation
Each member of the company's management board is entitled to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Worldwide Clinical Trials Holdings, Inc. | 6,589 | $88,992.44 | 99.8333% |
Others | 11 | $148.57 | 0.1667% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2010-07-15.
35 1280 0003 0000 0031 5862 3031
14 1280 0003 0000 0031 5862 3021
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Polska Sieć Handlowa LivioS.A. | $12,562,226.67 | liviosklepy.pl | ||
| Bernas Engineeringsp. z o.o. | $10,416,593.05 | bernas-eng.pl | ||
| Nobipharmsp. z o.o. | $9,447,565.32 | nobipharm.pol.pl | ||
| Dolnośląski Park Innowacji I NaukiS.A. | $9,073,510.36 | dpin.pl | ||
| Rateart Dariusz Matyjewiczsp. k. | $9,045,428.26 | rateart.pl | ||
| EIT Food Clc North-Eastsp. z o.o. | $5,856,440.54 | eitfood.eu | ||
| Agriportsp. z o.o. | $3,542,479.97 | agriport.pl | ||
| Elgridsp. z o.o. | $3,445,225.01 | elgrid.pl | ||
| Envausp. z o.o. | $2,452,314.91 | envau.pl | ||
| Reeko Organizacja Odzysku OpakowańS.A. | $2,291,095.14 | reeko.pl |
Change history
| Date | Event | |
|---|---|---|
| 2023-07-03 | Address change (Plac Piłsudskiego 1, 00-078, Warszawa → Rondo Ignacego Daszyńskiego 2b, 00-843, Warszawa) | |
| 2015-09-11 | Share capital change (30,000.00 PLN → 330,000.00 PLN) | |
| 2015-09-11 | PKD change (Removed: 64.20.Z, 68.10.Z, 68.20.Z, 69.20.Z, 70.10.Z, 78.30.Z, 82.11.Z, 88.99.Z) | |
| 2010-06-18 | Entered in the register |
FAQ
The main business activity of Worldwide Clinical Trials Poland focuses on other professional, scientific and technical activities not elsewhere classified.
The company was registered in the Polish National Court Register (KRS) on June 18, 2010.
The headquarters is located at: Rondo Ignacego Daszyńskiego 2B, 00-843 Warszawa.
The share capital of the company is PLN 330,000 (approx. $89,141).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of USD 10,719,737 in 2025, which is an increase of 5.7% compared to 2024.
Yes, the company recorded a net profit of USD 650,928 in 2025, meaning the company increased its profit by 11.3%.
The largest operating cost category falls under employee remuneration. This category amounted to USD 7,886,905 in 2025, representing 80% of all operating expenses.
Last updated: 2026-10-05